Traws Pharma, Inc. Research and Development Expense
Traws Pharma, Inc. (TRAW) reported Research and Development Expense of $1.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-14
- Traws Pharma, Inc. research and development expense for the quarter ending 2026-06-30 was $1.10M, a 51.94% decline year-over-year.
- Traws Pharma, Inc. research and development expense for the quarter ending 2026-03-31 was $4.91M, a 96.01% increase year-over-year.
- Traws Pharma, Inc. research and development expense for the quarter ending 2025-06-30 was $2.29M.
- Traws Pharma, Inc. research and development expense for the quarter ending 2025-03-31 was $2.51M, a 31.07% increase year-over-year.
- Traws Pharma, Inc. research and development expense for fiscal 2023 was $11.43M, a 0.21% increase from fiscal 2022.
- Traws Pharma, Inc. research and development expense for fiscal 2022 was $11.41M, a 56.31% increase from fiscal 2021.
- Traws Pharma, Inc. research and development expense for fiscal 2021 was $7.30M, a 56.82% decline from fiscal 2020.
- Traws Pharma, Inc. research and development expense for fiscal 2020 was $16.90M, a 8.76% increase from fiscal 2019.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.10M 10-Q · filed 2026-08-14 | $6.01M 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | $4.91M 10-Q · filed 2026-05-15 | |||
| 2025-06-30 | $2.29M 10-Q · filed 2026-08-14 | $4.80M 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | $2.51M 10-Q · filed 2026-05-15 | |||
| 2024-03-31 | $1.91M 10-Q · filed 2024-05-15 | $4.35M derived: sum of 2 quarters · filed 2024-05-15 | $6.81M derived: sum of 3 quarters · filed 2024-05-15 | $9.26M derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-12-31 | $2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $4.89M derived: sum of 2 quarters · filed 2024-04-01 | $7.35M derived: sum of 3 quarters · filed 2024-04-01 | $11.43M 10-K · filed 2024-04-01 |
| 2023-09-30 | $2.46M 10-Q · filed 2023-11-14 | $4.92M derived: sum of 2 quarters · filed 2023-11-14 | $9.00M 10-Q · filed 2023-11-14 | $12.77M derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-06-30 | $2.46M 10-Q · filed 2023-08-14 | $6.54M 10-Q · filed 2023-08-14 | $10.31M derived: sum of 3 quarters · filed 2024-05-15 | $13.90M derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-03-31 | $4.08M 10-Q · filed 2024-05-15 | $7.85M derived: sum of 2 quarters · filed 2024-05-15 | $11.45M derived: sum of 3 quarters · filed 2024-05-15 | $13.48M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $3.77M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $7.37M derived: sum of 2 quarters · filed 2024-04-01 | $9.40M derived: sum of 3 quarters · filed 2024-04-01 | $11.41M 10-K · filed 2024-04-01 |
| 2022-09-30 | $3.59M 10-Q · filed 2023-11-14 | $5.63M derived: sum of 2 quarters · filed 2023-11-14 | $7.63M 10-Q · filed 2023-11-14 | $9.38M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $2.04M 10-Q · filed 2023-08-14 | $4.04M 10-Q · filed 2023-08-14 | $5.79M derived: sum of 3 quarters · filed 2023-08-14 | $7.55M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $2.00M 10-Q · filed 2023-05-15 | $3.75M derived: sum of 2 quarters · filed 2023-05-15 | $5.51M derived: sum of 3 quarters · filed 2023-05-15 | $7.36M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $3.51M derived: sum of 2 quarters · filed 2023-03-30 | $5.36M derived: sum of 3 quarters · filed 2023-03-30 | $7.30M 10-K · filed 2023-03-30 |
| 2021-09-30 | $1.76M 10-Q · filed 2022-11-14 | $3.62M derived: sum of 2 quarters · filed 2022-11-14 | $5.55M 10-Q · filed 2022-11-14 | $10.09M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $1.85M 10-Q · filed 2022-08-15 | $3.79M 10-Q · filed 2022-08-15 | $8.32M derived: sum of 3 quarters · filed 2022-08-15 | $12.52M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $1.94M 10-Q · filed 2022-05-13 | $6.47M derived: sum of 2 quarters · filed 2022-05-13 | $10.66M derived: sum of 3 quarters · filed 2022-05-13 | $15.46M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $4.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $8.73M derived: sum of 2 quarters · filed 2022-03-21 | $13.53M derived: sum of 3 quarters · filed 2022-03-21 | $16.90M 10-K · filed 2022-03-21 |
| 2020-09-30 | $4.19M 10-Q · filed 2021-11-15 | $8.99M derived: sum of 2 quarters · filed 2021-11-15 | $12.36M 10-Q · filed 2021-11-15 | $16.41M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $4.80M 10-Q · filed 2021-08-16 | $8.17M 10-Q · filed 2021-08-16 | $12.22M derived: sum of 3 quarters · filed 2021-08-16 | $15.74M derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $3.37M 10-Q · filed 2021-05-17 | $7.42M derived: sum of 2 quarters · filed 2021-05-17 | $10.94M derived: sum of 3 quarters · filed 2021-05-17 | $14.83M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $4.05M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $7.57M derived: sum of 2 quarters · filed 2021-03-18 | $11.46M derived: sum of 3 quarters · filed 2021-03-18 | $15.54M 10-K · filed 2021-03-18 |
| 2019-09-30 | $3.52M 10-Q · filed 2020-11-16 | $7.42M derived: sum of 2 quarters · filed 2020-11-16 | $11.49M 10-Q · filed 2020-11-16 | $15.78M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $3.90M 10-Q · filed 2020-08-12 | $7.97M 10-Q · filed 2020-08-12 | $12.26M derived: sum of 3 quarters · filed 2020-08-12 | $16.25M derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $4.08M 10-Q · filed 2020-05-15 | $8.37M derived: sum of 2 quarters · filed 2020-05-15 | $12.35M derived: sum of 3 quarters · filed 2020-05-15 | $16.42M derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $4.29M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $8.28M derived: sum of 2 quarters · filed 2020-03-27 | $12.35M derived: sum of 3 quarters · filed 2020-03-27 | $16.92M 10-K · filed 2020-03-27 |
| 2018-09-30 | $3.98M 10-Q · filed 2019-11-12 | $8.05M derived: sum of 2 quarters · filed 2019-11-12 | $12.63M 10-Q · filed 2019-11-12 | $17.11M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $4.07M 10-Q · filed 2019-08-14 | $8.65M 10-Q · filed 2019-08-14 | $13.13M derived: sum of 3 quarters · filed 2019-08-14 | $18.27M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $4.58M 10-Q · filed 2019-05-15 | $9.05M derived: sum of 2 quarters · filed 2019-05-15 | $14.20M derived: sum of 3 quarters · filed 2019-05-15 | $18.81M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $4.48M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $9.62M derived: sum of 2 quarters · filed 2019-04-01 | $14.23M derived: sum of 3 quarters · filed 2019-04-01 | $19.12M 10-K · filed 2019-04-01 |
| 2017-09-30 | $5.14M 10-Q · filed 2018-11-14 | $9.76M derived: sum of 2 quarters · filed 2018-11-14 | $14.64M 10-Q · filed 2018-11-14 | $19.34M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $4.61M 10-Q · filed 2018-08-14 | $9.50M 10-Q · filed 2018-08-14 | $14.19M derived: sum of 3 quarters · filed 2018-08-14 | $18.18M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $4.89M 10-Q · filed 2018-05-15 | $9.58M derived: sum of 2 quarters · filed 2018-05-15 | $13.57M derived: sum of 3 quarters · filed 2018-05-15 | $19.14M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | $4.69M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $8.69M derived: sum of 2 quarters · filed 2018-03-16 | $14.25M derived: sum of 3 quarters · filed 2018-03-16 | $20.07M 10-K · filed 2018-03-16 |
| 2016-09-30 | $3.99M 10-Q · filed 2017-11-09 | $9.55M derived: sum of 2 quarters · filed 2017-11-09 | $15.38M 10-Q · filed 2017-11-09 | $19.98M derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | $5.56M 10-Q · filed 2017-08-14 | $11.39M 10-Q · filed 2017-08-14 | $15.99M derived: sum of 3 quarters · filed 2017-08-14 | $21.27M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $5.82M 10-Q · filed 2017-05-15 | $10.43M derived: sum of 2 quarters · filed 2017-05-15 | $15.71M derived: sum of 3 quarters · filed 2017-05-15 | $22.22M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $4.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $9.88M derived: sum of 2 quarters · filed 2017-03-29 | $16.40M derived: sum of 3 quarters · filed 2017-03-29 | $25.89M 10-K · filed 2017-03-29 |
| 2015-09-30 | $5.28M 10-Q · filed 2016-11-14 | $11.79M derived: sum of 2 quarters · filed 2016-11-14 | $21.29M 10-Q · filed 2016-11-14 | $31.68M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $6.51M 10-Q · filed 2016-08-15 | $16.01M 10-Q · filed 2016-08-15 | $26.40M derived: sum of 3 quarters · filed 2016-08-15 | $38.28M derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-03-31 | $9.50M 10-Q · filed 2016-05-11 | $19.89M derived: sum of 2 quarters · filed 2016-05-11 | $31.77M derived: sum of 3 quarters · filed 2016-05-11 | $44.67M derived: sum of 4 quarters · filed 2016-05-11 |
| 2014-12-31 | $10.39M 10-K · filed 2015-03-30 | $22.27M derived: sum of 2 quarters · filed 2015-11-12 | $35.18M derived: sum of 3 quarters · filed 2015-11-12 | $49.42M 10-K · filed 2016-03-28 |
| 2014-09-30 | $11.89M 10-Q · filed 2015-11-12 | $24.79M derived: sum of 2 quarters · filed 2015-11-12 | $39.04M 10-Q · filed 2015-11-12 | $51.12M derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-06-30 | $12.90M 10-Q · filed 2015-08-13 | $27.15M 10-Q · filed 2015-08-13 | $39.24M derived: sum of 3 quarters · filed 2015-08-13 | $54.53M derived: sum of 4 quarters · filed 2015-08-13 |
| 2014-03-31 | $14.25M 10-Q · filed 2015-05-15 | $26.33M derived: sum of 2 quarters · filed 2015-05-15 | $41.63M derived: sum of 3 quarters · filed 2015-05-15 | $51.67M derived: sum of 4 quarters · filed 2015-05-15 |
| 2013-12-31 | $12.09M 10-K · filed 2015-03-30 | $27.38M derived: sum of 2 quarters · filed 2015-03-30 | $37.43M derived: sum of 3 quarters · filed 2015-03-30 | $50.18M 10-K · filed 2015-03-30 |
| 2013-09-30 | $15.29M 10-K · filed 2015-03-30 | $25.34M derived: sum of 2 quarters · filed 2015-03-30 | $38.10M 10-Q · filed 2014-11-14 | $48.67M derived: sum of 4 quarters · filed 2015-03-30 |
| 2013-06-30 | $10.05M 10-K · filed 2015-03-30 | $22.80M 10-Q · filed 2014-08-14 | $33.38M derived: sum of 3 quarters · filed 2015-03-30 | $60.34M derived: sum of 4 quarters · filed 2015-03-30 |
| 2013-03-31 | $12.76M 10-K · filed 2015-03-30 | $23.33M derived: sum of 2 quarters · filed 2015-03-30 | $50.29M derived: sum of 3 quarters · filed 2015-03-30 | $57.07M derived: sum of 4 quarters · filed 2015-03-30 |
| 2012-12-31 | $10.58M 10-K · filed 2014-03-20 | $37.54M derived: sum of 2 quarters · filed 2014-03-20 | $44.31M derived: sum of 3 quarters · filed 2014-03-20 | $52.76M 10-K · filed 2015-03-30 |
| 2012-09-30 | $26.96M 10-K · filed 2014-03-20 | $33.74M derived: sum of 2 quarters · filed 2014-03-20 | $42.19M 10-Q · filed 2013-11-14 | |
| 2012-06-30 | $6.78M 10-K · filed 2014-03-20 | $15.22M 10-Q · filed 2013-09-06 | ||
| 2012-03-31 | $8.45M 10-K · filed 2014-03-20 | |||
| 2011-12-31 | $22.62M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |